NextPlat (NXPL) Asset Utilization Ratio (2016 - 2026)
NextPlat's (NXPL) quarterly Asset Utilization Ratio came in at 1.74 in Q2 2026, down 2.08% year-over-year from 1.77 in Q2 2025, and down 4.85% quarter-over-quarter from 1.83 in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Asset Utilization Ratio for 11 consecutive years, with 1.74 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 2.08% year-over-year to 1.74 in Q2 2026; TTM through Jun 2026 was 1.74, a 2.08% decrease from a year earlier, with the FY2025 full-year figure at 1.68, up 29.33% from the prior year.
- Asset Utilization Ratio was 1.74 for Q2 2026 at NextPlat, down from 1.83 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 1.87 in Q3 2025 and troughed at 0.38 in Q2 2023.
- A 5-year average of 1.09 and a median of 0.97 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio plunged 79.83% in 2022 and jumped 201.17% in 2024, its largest moves.
- Over 5 years, Asset Utilization Ratio stood at 0.48 in 2022, then advanced by 21.35% to 0.58 in 2023, then jumped by 192.54% to 1.69 in 2024, then rose by 10.57% to 1.87 in 2025, then decreased by 7.05% to 1.74 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.74 (Q2 2026), 1.83 (Q1 2026), and 1.87 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 0.44 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 0.67 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 0.23 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 0.73 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.74 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 |
| Mar 31, 2026 | 1.83 |
| Dec 31, 2025 | 1.87 |
| Sep 30, 2025 | 1.87 |
| Jun 30, 2025 | 1.77 |
| Mar 31, 2025 | 1.73 |
| Dec 31, 2024 | 1.69 |
| Sep 30, 2024 | 1.44 |
| Jun 30, 2024 | 1.14 |
| Mar 31, 2024 | 0.81 |
| Dec 31, 2023 | 0.58 |
| Sep 30, 2023 | 0.49 |
| Jun 30, 2023 | 0.38 |
| Mar 31, 2023 | 0.39 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.49 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | 0.38 |